title: The Impact of Technology on Current Diabetes Management.
abstract: Technological innovations have revolutionized the treatment of type 1 diabetes. Although technological advances can potentially improve diabetes outcomes, maintenance of target glycemic control, at the present time, remains largely dependent on patient and family motivation, competence, and adherence to daily diabetes care requirements. Trials of closed loop or "artificial pancreas" technology show great promise to automate insulin delivery and achieve near normal glucose control and reduced hypoglycemia with minimal patient intervention.
authors.affiliation: Division of Endocrinology, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA. Electronic address: katharine.garvey@childrens.harvard.edu.
authors.forename: Katharine
authors.initials: K
authors.lastname: Garvey
authors.affiliation: Division of Endocrinology, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
authors.forename: Joseph I
authors.initials: JI
authors.lastname: Wolfsdorf
mesh_terms: D015190:Blood Glucose Self-Monitoring; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D004059:Diffusion of Innovation; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D018670:Monitoring, Ambulatory; D019397:Pancreas, Artificial
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Adolescents; Artificial pancreas; Children; Continuous glucose monitoring; Insulin analogues; Insulin pump; Technology; Type 1 diabetes mellitus